AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglib GM 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Mas Life Science

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Voglib GM 2mg/500mg/0.2mg Tablet

Diabeva Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This triple-combination therapy is indicated for managing type 2 diabetes in adults. It effectively regulates blood glucose levels. Diabeva Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive treatment plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Consistent mealtimes and carrying a fast-acting glucose source (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Voglib GM 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Voglib GM 2mg/500mg/0.2mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Voglib GM 2mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Voglib GM 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglib GM 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglib GM 2mg/500mg/0.2mg Tablets should be administered on an empty stomach.

How Voglib GM 2mg/500mg/0.2mg Tablet works:

Each Voglib GM tablet (2mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Voglib GM 2mg/500mg/0.2mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglib GM 2mg/500mg/0.2mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglib GM 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose level is either elevated or deficient. Refrain from driving should these conditions arise.

KidneyKidneyUNSAFE

The use of Voglib GM 2mg/500mg/0.2mg Tablets is inadvisable for individuals with kidney impairment and should be forgone. Medical advice is essential. Furthermore, its use is contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Patients with liver impairment should use Voglib GM 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Voglib GM 2mg/500mg/0.2mg Tablet :

Should you forget to take a Voglib GM 2mg/500mg/0.2mg Tablet, administer it immediately. If your next scheduled dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglib GM 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Voglib GM 2mg/500mg/0.2mg Tablet

Voglib GM 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Voglib GM 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, rash, and respiratory infection.
Voglib GM 2mg/500mg/0.2mg Tablets are contraindicated in patients allergic to any ingredient or excipient. Their use is also contraindicated in those with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Voglib GM 2mg/500mg/0.2mg Tablet with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglib GM 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Voglib GM 2mg/500mg/0.2mg...
101
MRP 124
18% off